https://www.managedhealthcareexecutive.com/view/cytomegalovirus-update-for-the-first-time-a-phase-3-vaccine-trial-idweek-2023
Cytomegalovirus (CMV) expert Sallie Permar, M.D., Ph.D., of NewYork-Presbyterian/Weill Cornell Medical Center spoke about the phase 3 trial of Moderna’s mRNA vaccine against CMV and another candidate being developed by Merck that showed some promise in a phas…
Create an account or login to join the discussion